Growth Metrics

Eli Lilly (LLY) Free Cash Flow (2016 - 2026)

Eli Lilly filings provide 18 years of Free Cash Flow readings, the most recent being $3.0 billion for Q1 2026.

  • On a quarterly basis, Free Cash Flow rose 1827.56% to $3.0 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $11.8 billion, a 216.44% increase, with the full-year FY2025 number at $9.0 billion, up 138.62% from a year prior.
  • Free Cash Flow hit $3.0 billion in Q1 2026 for Eli Lilly, up from $677.9 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $6.7 billion in Q3 2025 to a low of -$1.4 billion in Q4 2023.
  • Median Free Cash Flow over the past 5 years was $1.1 billion (2023), compared with a mean of $1.3 billion.
  • Biggest five-year swings in Free Cash Flow: tumbled 219.02% in 2023 and later surged 1827.56% in 2026.
  • Eli Lilly's Free Cash Flow stood at $1.2 billion in 2022, then tumbled by 219.02% to -$1.4 billion in 2023, then skyrocketed by 170.69% to $977.7 million in 2024, then plummeted by 30.66% to $677.9 million in 2025, then soared by 343.58% to $3.0 billion in 2026.
  • The last three reported values for Free Cash Flow were $3.0 billion (Q1 2026), $677.9 million (Q4 2025), and $6.7 billion (Q3 2025) per Business Quant data.